• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.

作者信息

Nolte D, Dusik B

出版信息

Br J Clin Pract Suppl. 1984;32:18-21.

PMID:6432018
Abstract
摘要

相似文献

1
The tolerability of a new oral controlled release theophylline preparation in patients with obstructive airways diseases.一种新型口服控释茶碱制剂在阻塞性气道疾病患者中的耐受性
Br J Clin Pract Suppl. 1984;32:18-21.
2
Evaluation of the effectiveness and safety of a controlled-release theophylline in patients with reversible and stable bronchial obstruction.对控释茶碱在可逆性稳定支气管阻塞患者中的有效性和安全性进行评估。
Int J Clin Pharmacol Res. 1987;7(5):337-44.
3
Clinical results obtained from a new controlled release theophylline preparation.从一种新型控释茶碱制剂获得的临床结果。
Br J Clin Pract Suppl. 1984;32:14-7.
4
[Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].[新型口服长效茶碱在阻塞性气道疾病患者中的耐受性]
Fortschr Med. 1983 Jul 7;101(25):1203-6.
5
[Clinico-laboratory evaluation a new sustained-release preparation of anhydrous theophylline].[无水茶碱新缓释制剂的临床实验室评估]
Clin Ter. 1989 Dec 15;131(5):293-7.
6
[Long-term therapy with a retard theophylline preparation].[使用缓释茶碱制剂的长期治疗]
Fortschr Med. 1995 May 10;113(13):197-202.
7
[Treatment of chronic obstructive respiratory disease with a new purified theophylline preparation in delayed-action form].[用新型缓释型纯化茶碱制剂治疗慢性阻塞性呼吸道疾病]
Wien Med Wochenschr. 1984 Apr 15;134(7):163-9.
8
[Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].[每日单次服用新型无水茶碱缓释制剂治疗可逆性支气管阻塞的疗效。与每日两次服用的缓释制剂的比较]
Clin Ter. 1987 Sep 30;122(6):437-40.
9
[Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].["一种新型“每日一次”无水茶碱延迟作用制剂用于慢性阻塞性支气管肺炎患者的临床功能研究"]
Clin Ter. 1989 Jul 15;130(1):45-9.
10
[Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
Fortschr Med. 1997 Jan 20;115(1-2):54-5.